Review: The immune response in human tuberculosis - Implications for tuberculosis control

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1351-1359

  Ellner, Jerrold J ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; UNITED STATES;

EID: 0030830879     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514132     Document Type: Review

References (15)

1. Colditz GA, Brewer TF, Berkeley CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta analysis of the published literature. JAMA 1994;271:698-702.
2. Havlir DV, van der Kuyp F, Duffy E, Marshall R, Hom D, Ellner JJ. Nineteen year follow-up of tuberculin reactors: assessment of skin test reactivity and in vitro lymphocyte response. Chest 1991;99:1172-6.
3. Bange FC, Brown AM, Jacobs WR Jr. Leucine aaxotrophy restricts growth of Mycobacterium bovis BCG in macrophages. Nature (in press).
4. Comstock GW. Identification of an effective vaccine against tuberculosis. Am Rev Respir Dis 1988;138:79-80.
5. D'Souza CD, Cooper AM, Frank AA, et al. An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol 1997;158:1217-21.
6. Flynn JL, Chan J, Triebord KJ, Dalton DK, Stewart TA, Bloom BS. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
7. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon γ gene-disrupted mice. J Exp Med 1993;178:2243-7.
8. Kindler V, Sappino AP, Grau GE, Pignet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bacterial granulomas during BCG infection. Cell 1989;76:731-40.
9. Chen J, Xing Y, Majliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992;175:1111-22.
10. Cooper AM, Robert AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis. Immunology 1995;84:423-32.
11. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995;155:2515-24.
12. Orme IM, Andersen P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993;167:1481-97.
13. Barnes PF, Modlin ML, Ellner JJ. T-cell responses and cytokines in tuberculosis: pathogenesis, protection and control. In: Bloom BR, ed. Tuberculosis. Washington, DC: American Society for Microbiology, 1994:417-35.
14. Hirsch CS, Yoneda T, Averill L, Ellner JJ, Toossi Z. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor beta (TGF-β). J Infect Dis 1994;170:1229-37.
15. Orme IM. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun 1988;56:3310-12.